Fibrinogen recovery and changes in fibrin‐based clot firmness after cryoprecipitate administration in patients undergoing aortic surgery involving deep hypothermic circulatory arrest

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Transfusion

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/trf.12479PMID 24192484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates.

  2013cited by this paper
• When do we transfuse cryoprecipitate?

  2013cited by this paper
• Thromboelastometric Maximum Clot Firmness in Platelet-Free Plasma Is Influenced by the Assay Used

  2013cited by this paper
• Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh‐frozen plasma inactivated with amotosalen and ultraviolet A light

  2013cited by this paper
• Effects of Fibrinogen Concentrate as First-line Therapy during Major Aortic Replacement Surgery: A Randomized, Placebo-controlled Trial

  2013cited by this paper
• Early thromboelastometric variables reliably predict maximum clot firmness in patients undergoing cardiac surgery: a step towards earlier decision making

  2013cited by this paper
• Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.

  2013cited by this paper
• Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test.

  2013cited by this paper
• Earlier detection of coagulopathy with thromboelastometry during pediatric cardiac surgery: a prospective observational study

  2013cited by this paper
• Point-of-Care Testing: A Prospective, Randomized Clinical Trial of Efficacy in Coagulopathic Cardiac Surgery Patients

  2012cited by this paper
• Cryoprecipitate: an outmoded treatment?

  2012cited by this paper
• A Prospective, Randomized Clinical Trial of Efficacy in Coagulopathic Cardiac Surgery Patients

  2012cited by this paper
• A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution‐induced coagulation changes after cardiac surgery

  2012cited by this paper
• First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.

  2011cited by this paper
• [Efficacy of cryoprecipitate transfusion for coagulopathy after cardiopulmonary bypass in thoracic aortic surgery].

  2011influential reference
• Cryoprecipitate transfusion: assessing appropriateness and dosing in trauma

  2011cited by this paper
• Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery.

  2011cited by this paper
• A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients

  2011cited by this paper
• A critical evaluation of cryoprecipitate for replacement of fibrinogen

  2010cited by this paper
• Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial.

  2010cited by this paper
• Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery

  2010cited by this paper
• Use of fibrin-based thromboelastometry for cryoprecipitate transfusion in cardiac surgery involving deep hypothermic circulatory arrest during cardiopulmonary bypass

  2010cited by this paper
• In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM®)

  2010cited by this paper
• Pharmacokinetics and safety of fibrinogen concentrate

  2009cited by this paper
• Thromboelastography‐Based Transfusion Algorithm Reduces Blood Product Use after Elective CABG: A Prospective Randomized Study

  2009cited by this paper
• Thrombin generation and clot formation in methylene blue–treated plasma and cryoprecipitate

  2009cited by this paper
• Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study

  2009cited by this paper
• Cryoprecipitate: the current state of knowledge.

  2009influential reference
• The Effects of Fibrinogen Levels on Thromboelastometric Variables in the Presence of Thrombocytopenia

  2009cited by this paper
• Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study.

  2009cited by this paper
• Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh‐frozen plasma

  2009cited by this paper
• Cryoprecipitate use in 25 Canadian hospitals: commonly used outside of the published guidelines

  2008cited by this paper
• Plasma fibrinogen level, bleeding, and transfusion after on‐pump coronary artery bypass grafting surgery: a prospective observational study

  2008cited by this paper
• Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery.

  2008cited by this paper
• The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass

  2008cited by this paper
• The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital.

  2008cited by this paper
• Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM).

  2007cited by this paper
• Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma.

  2006cited by this paper
• Pharmacokinetic properties of a pasteurised fibrinogen concentrate.

  2005cited by this paper
• Inflammatory response to cardiopulmonary bypass.

  2003cited by this paper
• Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes.

  1997cited by this paper
• The Inflammatory Response to Cardiopulmonary Bypass

  1996cited by this paper
• Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists.

  1994cited by this paper
• Blood component therapy.

  1988cited by this paper
• Cryoprecipitates in treatment of congenital fibrinogen deficiency. Case report.

  1969cited by this paper
• Cryoprecipitates in Treatment of Congenital Fibrinogen Deficiency

  1969cited by this paper

• 2024 Guidelines on Patient Blood Management for Adult Cardiac Surgery Under Cardiopulmonary Bypass in China

  2025cites this paper
• Amplitude at 10 min in thromboelastography predicts maximum amplitude: a single-center observational study

  2024cites this paper
• Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care

  2023cites this paper
• Association of perioperative cryoprecipitate transfusion and mortality after cardiac surgery.

  2023cites this paper
• Coagulation management during liver transplantation: monitoring and decision making for hemostatic interventions

  2023cites this paper
• The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major trauma haemorrhage requiring major haemorrhage protocol activation

  2022cites this paper
• Cryoprecipitate Transfusion After Cardiac Surgery.

  2022cites this paper
• Does Intraoperative Fibrinogen Affect Blood Loss or Transfusion Practice After Aortic Arch Surgery: A Prematurely Ended Randomized Trial

  2022cites this paper
• The role of fibrinogen in traumatic brain injury: from molecular pathological mechanisms to clinical management

  2022cites this paper
• Pediatric Fibrinogen PART II—Overview of Indications for Fibrinogen Use in Critically Ill Children

  2021cites this paper
• Hematologic evaluation of intraoperative autologous blood collection and allogeneic transfusion in cardiac surgery

  2021cites this paper
• Pediatric Fibrinogen PART I—Pitfalls in Fibrinogen Evaluation and Use of Fibrinogen Replacement Products in Children

  2021cites this paper
• Fibrinogen and Bleeding in Adult Cardiac Surgery: A Review of the Literature

  2021cites this paper
• Risk Factors and Outcomes of Acute Kidney Injury after Type A Aortic Dissection Surgery at A Tertiary Care Hospital

  2021cites this paper
• Cryoprecipitate transfusion in bleeding patients.

  2020cites this paper
• More Is Not Always Better: Effects of Cell Salvage in Cardiac Surgery on Postoperative Fibrinogen Concentrations.

  2020cites this paper
• Clinical guidelines for cryoprecipitate transfusions

  2020cites this paper
• Клиническое использование криопреципитата

  2020cites this paper
• Rotational Thromboelastometry (ROTEM®)

  2020cites this paper
• Efficacy of fibrinogen concentrate in major abdominal surgery – A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei

  2019cites this paper
• Crotalus atrox venom preconditioning increases plasma fibrinogen and reduces perioperative hemorrhage in a rat model of surgical brain injury

  2017cites this paper
• Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016.

  2017cites this paper
• Fibrinogen in traumatic haemorrhage: A narrative review.

  2017cites this paper
• A New Intraoperative Protocol for Reducing Perioperative Transfusions in Cardiac Surgery.

  2017cites this paper
• Maintaining Plasma Fibrinogen Levels and Fibrinogen Replacement Therapies for Treatment of Intracranial Hemorrhage.

  2017cites this paper
• Blood Products, Derivates, and Prohemostatic Drugs

  2016cites this paper
• Anesthetic Considerations for Surgery on the Aortic Arch

  2016cites this paper
• Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review

  2016cites this paper
• Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial.

  2015cites this paper
• Layered wrapping technique combined with oxidized cellulose and vascular prosthesis for effective haemostasis in aortic surgery.

  2015cites this paper
• COMPUTED TOMOGRAPHY OR CHEST RADIOGRAPH SURVEILLANCE FOLLOWING STAGE I

  2015cites this paper
• El crioprecipitado: ese viejo desconocido

  2015cites this paper
• Fibrinogen concentrate as first-line therapy in children undergoing cardiac surgery: Promising perspectives.

  2015cites this paper
• Treat How I use fi brinogen replacement therapy in acquired bleeding

  2015cites this paper
• How I use fibrinogen replacement therapy in acquired bleeding.

  2015cites this paper
• Blood Products

  2015cites this paper
• [The cryoprecipitate: that old unknown].

  2015cites this paper
• Cryoprecipitate therapy

  2014cites this paper
• Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate

  2014cites this paper
• Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology.

  2013cites this paper